Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Yue ^a,b   Zhang, Zhaolei ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR PROTEIN;

BOOK; CARCINOGENESIS; CELL COMMUNICATION; EXOSOME; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; METASTASIS; MOLECULAR GENETICS; MORTALITY; NEOPLASMS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; SURVIVAL; TRANSPORT AT THE CELLULAR LEVEL;

ATLASES AS TOPIC; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CARCINOGENESIS; CELL COMMUNICATION; DATABASES, GENETIC; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84923331613     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07097     Document Type: Article

References (51)

1. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006)
2. Bartel, D. P. MicroRNAs: Target Recognition and Regulatory Functions. Cell 136, 215-233 (2009)
3. Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (1993)
4. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005)
5. Dvinge, H. et al. The shaping and functional consequences of the microrna landscape in breast cancer. Nature 497, 378-382 (2013)
6. Jacobsen, A. et al. Analysis of microRNA-target interactions across diverse cancer types. Nat. Struct. & Mol. Biol. 20, 1325-1332 (2013)
7. Chen, X., Slack, F. J. & Zhao,H. Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions. Bioinformatics 29, 2137-2145 (2013)
8. Li, Y., Liang, C.,Wong, K.-C., Jin, K. & Zhang, Z. Inferring probabilistic miRNAmRNA interaction signatures in cancers: a role-switch approach. Nucleic Acids Res. 42, e76 (2014)
9. Friedman, R. C., Farh, K. K.-H., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009)
10. Betel, D., Koppal, A.,Agius, P., Sander, C. &Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010)
11. Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding. Cell 153, 654-665 (2013)
12. Grosswendt, S. et al. Unambiguous identification of mirna:target site interactions by different types of ligation reactions. Mol. Cell 54, 1042-1054 (2014)
13. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008)
14. Weinstein, J.N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120 (2013)
15. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010)
16. Hu, G., Drescher, K.M. & Chen, X. Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front. Genet. 3 (2012)
17. Mermel, C. H. et al. GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12, R41 (2011)
18. Efron, B. Large-Scale Simultaneous Hypothesis Testing. J. Am. Stat. Assoc. 99, 96-104 (2004)
19. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 289-300 (1995)
20. Hsu, S.-D. et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, D163-D169 (2011)
21. Spizzo, R., Nicoloso, M. S., Croce, C. M. & Calin, G. A. SnapShot: MicroRNAs in Cancer. Cell 137, 586-586 (2009)
22. Koturbash, I., Zemp, F. J., Pogribny, I. & Kovalchuk, O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat. Res. 722, 94-105 (2011)
23. Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945-D950 (2011)
24. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003)
25. Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68-D73 (2014)
26. Hyun, S. et al. Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 139, 1096-1108 (2009)
27. Nam, E. J. et al.MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 14, 2690-2695 (2008)
28. Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelialmesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914 (2008)
29. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009)
30. Kanehisa, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199-D205 (2014)
31. Zaman, N. et al. Signaling Network Assessment of Mutations and Copy Number Variations PredictBreast Cancer Subtype-Specific Drug Targets. CellReports 5, 216-223 (2013)
32. Rice, P., Longden, I. & Bleasby, A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16, 276-277 (2000)
33. Massague, J. TGFb in cancer. Cell 134, 215-230 (2008)
34. Chen, H.-Y. et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631-3641 (2012)
35. Piao, L. et al. Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Mol. Ther. 20, 1261-1269 (2012)
36. Cassimeris, L., Lingappa, V. R., Plopper, G. & Lewin, B. The extracellular matrix and cell adhesion, Lewins CELLS. pp 821-878 (Jones &Bartlett Learning, Sudbury, MA, United States of America, 2011), second edn
37. Liotta, L. A. et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68 (1980)
38. Li, J. et al. Identification of high-quality cancer prognostic markers andmetastasis network modules. Nat. Commun. 1, 34 (2010)
39. Therneau, T. M. Modeling survival data: extending the Cox model (Springer, New York, 2000)
40. Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymphspecific receptor for hyaluronan. J. Cell Biol. 144, 789-801 (1999)
41. Du, Y. et al. The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells. PLoS One 8, e63463 (2013)
42. Ramani, P., Dungwa, J. V. & May, M. T. LYVE-1 upregulation and lymphatic invasion correlate with adverse prognostic factors and lymph node metastasis in neuroblastoma. Virchows Arch. 460, 183-191 (2012)
43. Tsuchida, A. et al. Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alphaseries gangliosides. J. Biol. Chem. 278, 22787-22794 (2003)
44. Huang, J. C. et al. Using expression profiling data to identify human microRNA targets. Nat. Methods 4, 1045-1049 (2007)
45. Lu, Y., Zhou, Y., Qu, W., Deng, M. & Zhang, C. A Lasso regression model for the construction of microRNA-target regulatory networks. Bioinformatics 27, 2406-2413 (2011)
46. Li, Y., Goldenberg, A., Wong, K.-C. & Zhang, Z. A probabilistic approach to explore human miRNA targetome by integrating miRNA-overexpression data and sequence information. Bioinformatics 30, 621-628 (2014)
47. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2011)
48. Hunter, M. P. et al.Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694 (2008)
49. Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452 (2010)
50. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification fromRNA-Seq data with or without a reference. BMC Bioinformatics 12, 323 (2011)
51. Frankel, L. B. et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033 (2008)